Midtown Center for Treatment and Research

The Midtown Center is a comprehensive not-for-profit outpatient program for the evaluation and treatment of chemically dependent individuals and their significant others. The program is licensed by the New York State Office of Alcoholism and Substance Abuse Services (OASAS) as a Medically Supervised Ambulatory Substance Abuse Treatment Program.

Download the Midtown Center brochure (pdf).

The Center now also has programs for combat veterans with PTSD (in conjunction with the Headstrong Project) as well as for their spouses or significant others.

As a program of Cornell University's Weill Medical College, a world-renowned academic and research institution, staff take part in and are exposed to cutting-edge research exploring the mechanisms and treatment of substance abuse. The clinical team members reflect rich and diverse academic backgrounds from the fields of medicine, psychology, social work, and counseling with special interest and certification in the field of alcoholism and substance abuse.


Every effort will be made to schedule an initial consultation within twenty-four hours of the referral date. Intake and Treatment Evaluation includes one intake evaluation session, a medical evaluation by a member of Midtown Center's medical staff and a urine toxicology screen. If appropriate, a psychiatric evaluation is also completed. All patients are expected to participate in the Intake and Treatment Evaluation that will culminate in an individualized treatment plan and will include any combination of the following services:

  • Suboxone Treatment Program
  • Suboxone Induction/Treatment
  • Naltrexone Therapy
  • Antabuse Therapy
  • Campral Therapy
  • Program for Spouses and Significant Others
  • Intensive Day Program
  • Supervised Urine Surveillance
  • Relapse Prevention Training
  • EAP and Managed Care Reporting
  • Anger Management
  • Case Management
  • Didactic Groups
  • Family Therapy and Education
  • Assertiveness Training
  • AIDS Counseling and Education
  • Orientation Groups
  • Group Psychotherapy
  • Combat Veterans with Addiction Issues
  • Men's Groups and Women's Groups
  • Executive Group
  • Impaired Professionals' Groups
  • Dual Diagnosis Group
  • Psychiatric Evaluation and Treatment
  • Individual Psychotherapy
  • Psychopharmcologic Management
  • Ambulatory Benzodiazepine Detoxification
  • Program for Combat Veterans with PTSD

Financial Information

Insurance plans that are accepted include Medicaid, Aetna, Empire BC/BS, and self-payment. The Midtown Center also offers a sliding scale arrangement for qualifying clients.


To obtain more information about the Midtown Center for Treatment and Research or to refer a patient please contact:

The Midtown Center for Treatment and Research
56 West 45th Street - 9th Floor
New York, NY 10036
Phone: 212-764-5178
Fax: 212-764-5644

Administrative Director: Christopher Sturiano, PhD
Medical Director: Ann B. Beeder, MD
Patient Coordinator: Carlos Salinas

Office Hours

Monday: 9:00 AM - 5:00 PM
Tuesday: 9:00 AM - 8:00 PM
Wednesday: 9:00 AM - 8:00 PM
Thursday: 9:00 AM - 8:00 PM
Friday: 9:00 AM - 5:00 PM


The Midtown Center is at 56 West 45th Street (9th Floor), between 5th and 6th Avenues.

By subway:
4, 5, or 6 train to Grand Central Station
7 train to 5th Avenue
N, Q, R, W, 1, 2, or 3 train to Times Square
B, D, F or M train to 42nd Street Bryant Park or 47-50th Streets Rockefeller Center

By bus: http://mta.info/nyct/maps/manbus.pdf

On Facebook:

Contact Us

Division of Public Health Programs
Ann B. Beeder, MD, Chief

Gerard Ilaria, Administrator
409 East 60th Street, Room 3-305
Tel: (212) 746-5917

Mailing Address
Weill Cornell Medical College
Division of Public Health Programs
1163 York Avenue
New York, NY 10065

Patient Appointments & Inquiries

Midtown Center (including Suboxone Program)
Tel: (212) 764-5178

Employee Assistance Program Consortium
Tel: (212) 746-5890

Vincent P. Dole Treatment and Research Institute
Tel: (212) 746-1252

Headstrong Project
Tel: (212) 746-5917

Clinical Trials

View open clinical trials

Top of page